“At Moffitt [Cancer Center], I am a thoracic surgeon, which means I do surgery on the various cancers of the chest which is, of course, mostly lung cancer but also includes things like thymoma, mesothelioma, and a variety of other kinds of less common cancers,” said Dr. Robinson.
Dr. Robinson is a valued member of Moffitt Cancer Center’s Mesothelioma Research and Treatment Program. In addition to his ongoing surgical and clinical work, he is an accomplished cancer research with more than 150 published articles.
Dr. Robinson has been a surgical oncologist for over 20 years and speaks both English and Spanish.
Dr. Robinson’s Location
Moffitt Cancer Center
12902 Magnolia Drive
Tampa, FL, 33612
Dr. Robinson’s Career Highlights
- Director of Cardiothoracic Surgery at H. Lee Moffitt Cancer Center
- Running a Phase 2 clinical trial for a potential new mesothelioma treatment called transarterial chemoperfusion
- Contributed to more than 150 articles published in medical journals and books
- Over two decades experience treating various forms of cancer
Dr. Robinson’s Background
Dr. Lary Robinson began his post-secondary education at the University of Kansas, where he received an undergraduate bachelor of arts degree. He then began medical training at the Washington University School of Medicine, located in St. Louis, where he received his MD. From there, Dr. Robinson joined the surgical team at Duke University Medical Center, completing both an internship and residencies.
Dr. Robinson went abroad to the St. Thomas Hospital in London, England, where he completed a cardiac research and clinical cardiac surgery residency. During the Vietnam War, Dr. Robinson served his country as a Flight Surgeon, stationed at a United States Armed Forces base in Thailand. He is now the Director of Cardiothoracic Surgery at H. Lee Moffitt Cancer Center, a highly respected comprehensive care facility.
Because of his experience and talent as a surgeon, Dr. Robinson has been able to share his expertise at several top-notch medical schools throughout the U.S. He was the Clinical Director of the Clinical Perfusion Science Education Program at the University of Nebraska Medical Center, and is currently a Professor of Thoracic Surgery and Interdisciplinary Oncology at the University of South Florida College of Medicine.
Dr. Robinson was a strong contributor to the early research and understanding of mesothelioma, writing several articles about the disease before it was well-known within the medical community. This research and education focused primarily on the most aggressive surgical technique, extrapleural pneumonectomy.
Since then, Dr. Robinson has continued to make notable contributions to mesothelioma treatment and research. He has helped administer several clinical trials, including as principal investigator, the lead researcher on a trial.
Dr. Robinson is a talented, board-certified surgical oncologist who specializes in difficult lung cancers, including mesothelioma. He is particularly interested in aggressive surgical techniques, such as extrapleural pneumonectomy (EPPC), but is also actively researching new palliative chemotherapy options for mesothelioma patients.
Dr. Robinson’s additional specialties are many and varied, including minimally invasive surgery, video-assisted thoracic surgery (VATS), protective lung ventilation, lung neoplasms, and nutrition. He has researched new techniques for a variety of surgical procedures, the hypothesis that some lung cancers are caused by microbes, and hundreds of additional thoracic and oncology topics.
Dr. Robinson’s Career Accomplishments
Dr. Robinson has contributed to many areas of thoracic surgery, including mesothelioma. He has been at the forefront of surgical treatment options for mesothelioma since their early creation, and has continued to adapt to and create new mesothelioma therapies in the years since. He is highly experience with aggressive surgical techniques, such as extrapleural pneumonectomies, as well as palliative care options.
Dr. Robinson has won numerous awards for his contributions to the medical community and is recognized as a respected and experienced surgeon. He has had over 150 works published, lectured in classrooms and symposiums around the world, and helped educate the next generation of thoracic surgeons.
Awards & Honours
- Physician of the Year Award
- America’s Top Doctors
- America’s Top Doctors for Cancer
- Top Doctors: Florida
- Distinguished Service Award, Clinical Perfusion Science Faculty
- Fellow (FACCP)
- ACS Fellow
- Air Force Commendation Medal for Meritorious Service
Dr. Robinson’s Current Work
Dr. Robinson is a surgical oncologist with extensive experience treating lung and other thoracic cancers. He takes an aggressive approach to mesothelioma, most commonly starting with an extrapleural pneumonectomy, which permanently removes the infected lung and some of the surrounding tissues. Next, he often prescribes radiation therapy and chemotherapy.
Dr. Robinson is also studying new and improved mesothelioma treatments, including the use of transarterial chemoperfusion. This local chemo treatment is applied directly to a patient’s arteries and may be a viable and less invasive alternative to heated chemotherapy.
Dr. Robinson is a member of numerous professional organizations, including:
- Co-Director – Center for Infection Research in Cancer (CIRC)
- President – Prelude to a Cure (Non-Profit Lung Cancer Research Foundation)
- Chair – Credential Committee (Moffitt Cancer Center)
- Member – American Association for Thoracic Surgery
- Member – American College of Chest Physicians
- Member – American College of Surgeons
Current Clinical Trials by Dr. Robinson
Dr. Lary Robinson is part of the team at Moffitt Cancer Center that is researching transarterial chemoperfusion as a treatment option for mesothelioma patients. Their current clinical trial, “A Phase 2 Study of Transarterial Chemoperfusion Treatment”, is reviewing patient outcomes for this approach.
Transarterial chemoperfusion is a procedure in which chemotherapy drugs are injected into the arterial system and target the specific vessels that are supplying the mesothelioma tumor. It’s a less invasive surgery than heated chemotherapy, and is considered a palliative option for malignant pleural mesothelioma. Traditionally, these patients are treated with chemotherapy and radiation therapy.
Moffitt Cancer Center’s research into transarterial chemoperfusion treatment is incredibly important, as it presents a potential option for people who aren’t candidates for surgery because their health is too poor, the mesothelioma is not removable, or the patient simply doesn’t want an aggressive surgical procedure. In addition, transarterial chemoperfusion is less invasive than heated chemotherapy or HIPEC, the alternative local chemotherapy treatment for mesothelioma patients.
Dr. Robinson’s Healing Philosophy
As a member of Moffitt Cancer Center’s mesothelioma team, Dr. Robinson treats his patients using a comprehensive approach. He works as part of a multidisciplinary team to diagnose each patient and develop a treatment plan that is most likely to have the best possible outcome.
These plans are unique to each patient, as Dr. Robinson recognizes that every instance of cancer is unique. In addition, Dr. Robinson shares Moffitt’s dedication to exploring new treatment options and researching potential cures for mesothelioma and other types of cancer.